YCYi-Sheng Chang

Yi-Sheng Chang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yi-Sheng Chang has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Chun-Chieh Lai

    Department of Ophthalmology, College of Medicine, National Cheng Kung University, Tainan, Taiwan

    4 shared publications
  • Sung-Huei Tseng

    Department of Ophthalmology, Chi Mei Medical Center, Tainan 710, Taiwan

    4 shared publications
  • Sheng-Min Hsu

    Department of Ophthalmology, College of Medicine, National Cheng Kung University, Tainan, Taiwan

    3 shared publications
  • Shih-Hao Wang

    Department of Ophthalmology, College of Medicine, National Cheng Kung University, Tainan, Taiwan

    3 shared publications
  • Yi-Hsun Huang

    Department of Ophthalmology, College of Medicine, National Cheng Kung University, Tainan, Taiwan

    3 shared publications
  • Yu-Ti Teng

    Department of Ophthalmology, College of Medicine, National Cheng Kung University, Tainan, Taiwan

    3 shared publications

Latest Publications

  • Open Access

    Mesona chinensis Extract Ameliorates Retinal Angiopathy in a Zebrafish Model of Diabetic Retinopathy by Targeting Thymidylate Synthase in Folate Metabolism

    by Shih-Wei Jao, Hsin-Hsuan Yu, Gang-Hui Lee, Ting-Wen Ma, Yi-Sheng Chang, Ming-Jer Tang, Bing-Hung Chen, Tzu-Fun Fu

    Retinal neovascularization in diabetic retinopathy (DR) is a major cause of vision loss. Folate-mediated one-carbon metabolism (OCM) is crucial for nucleotide synthesis and cell proliferation. We hypothesized that dysregulated OCM, particularly involving thymidylate synthase (TYMS), contributes to DR pathogenesis. Using a zebrafish DR model and human retinal endothelial cells, we assessed high glucose’s effects on retinal vessel development and TYMS expression. We measured changes in gene and protein expression of OCM enzymes (TYMS, DHFR, SHMT) via RT-PCR and Western blotting. TYMS overexpression (via tyms mRNA microinjection) increased DR angiogenesis severity. We evaluated the anti-angiogenic efficacy and safety of M. chinensis extract and one of its key compounds, quercetin, using vessel imaging, optomotor response assays, and developmental toxicity comparisons against 5-fluorouracil and methotrexate. High glucose upregulated TYMS expression at both mRNA and protein levels, driving retinal hyper-angiogenesis and visual impairment in DR zebrafish. The pro-angiogenic effects of TYMS are tissue-specific. M. chinensis and quercetin dose-dependently inhibited both pathological angiogenesis and glucose-induced TYMS expression. The anti-angiogenic effect of M. chinensis was found to be TYMS-dependent, as evidenced by its ability to reverse hyper-angiogenesis caused by TYMS overexpression. Crucially, M. chinensis exhibited minimal toxicity compared to conventional anti-folate drugs. TYMS, a key enzyme in folate-mediated OCM, contributes to the pathological retinal angiogenesis in zebrafish DR model. The natural extract M. chinensis represents a potent, and cost-effective intervention that can prevent glucose-induced retinal pathology by modulating TYMS activity, providing a safe and promising alternative for the prevention and management of DR.

  • Open Access

    Susac Syndrome Following COVID-19 Vaccination: A Case Report

    by Po-Jui Chen, Yi-Sheng Chang, Chen-Chee Lim, Yu-Kuei Lee

    Due to the COVID-19 pandemic, numerous vaccines have been developed for the disease. However, with large-scale vaccination has come the gradual emergence of immunological phenomena caused by these new vaccines. Herein, we report a 48-year-old female with a sudden onset of inferior visual field defects in the left eye following her first dose of the ChAdOx1 vaccine. Dilated fundus examination combined with optical coherence tomography and fluorescein angiography confirmed the diagnosis of branch retinal artery occlusion. Within 4 weeks following vaccination, symptoms associated with hearing impairment developed, and magnetic resonance imaging revealed leptomeningeal enhancement. The diagnosis of Susac syndrome (SS) was confirmed. The development of SS may be caused by endotheliopathy resulting from the molecular mimicry of the ChAdOx1 vaccine. Clinicians should be aware of the symptoms of SS, which may develop after COVID-19 vaccination. Further experimental surveillance and case–control studies are required to confirm this relationship.


  • Open Access

    Author Correction: Major ocular trauma in Taiwan: 2002–2004 versus 2012–2014

    by Yi-Sheng Chang, Yu-Ti Teng, Yi-Hsun Huang, Mei-Ling Liu, Jia-Horung Hung, Sheng-Min Hsu, Fu-Chin Huang, Min-Hsiu Shih, Wan-Ju Chen, Chun-Chieh Lai, et al.

    A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.


  • Open Access

    Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan

    by Yi-Sheng Chang, Wan-Ju Lee, Chen-Chee Lim, Shih-Hao Wang, Sheng-Min Hsu, Yi-Chian Chen, Chia-Yi Cheng, Yu-Ti Teng, Yi-Hsun Huang, Chun-Chieh Lai, et al.

    This study investigated the “real-world” use of ranibizumab for neovascular age-related macular degeneration (nAMD) in Taiwan and assessed the visual outcome. We reviewed the medical records at National Cheng Kung University Hospital, Taiwan, during 2012–2014 for 264 consecutive eyes of 229 patients with nAMD, who applied for ranibizumab covered by national health insurance. A total of 194 eyes (73.5%) in 179 patients (65.5% men; mean ± standard deviation age 69.4 ± 10.7 years) were pre-approved for treatment. Applications for treatment increased year by year, but approval rates decreased during this time. The major causes of rejection for funding were diseases mimicking nAMD, including macular pucker/epiretinal membrane, macular scarring, dry-type AMD, and possible polypoidal choroidal vasculopathy. After completion of three injections in 147 eyes, visual acuity significantly improved, gaining ≥1 line in 51.8% of eyes and stabilising in 38.3% of 141 eyes in which visual acuity was measured. The 114 eyes approved with only one application had a better visual outcome than the 27 eyes approved after the second or third applications. In conclusion, ranibizumab is effective for nAMD; however, approval after the second or third application for national health insurance cover is a less favourable predictor of visual outcome.


  • Open Access

    Major ocular trauma in Taiwan: 2002–2004 versus 2012–2014

    by Yi-Sheng Chang, Yu-Ti Teng, Yi-Hsun Huang, Mei-Ling Liu, Jia-Horung Hung, Sheng-Min Hsu, Fu-Chin Huang, Min-Hsiu Shih, Wan-Ju Chen, Chun-Chieh Lai, et al.

    We investigated the temporal changes in major eye injuries in Taiwan by reviewing the medical records of all patients with ocular trauma hospitalized at the National Cheng Kung University Hospital during 2002–2004 and 2012–2014. A total of 169 eyes (161 patients) during 2002–2004 and 121 eyes (120 patients) during 2012–2014 were enrolled (mean ± SD age: 41.9 ± 20.8 years in 2002–2004, and 51.8 ± 19.3 years in 2012–2014). Males accounted for ~75% of patients. The most frequent injury-causing object was metallic material (~24%), and blunt traumas were most frequently attributable to traffic accidents and falls. The most common locations of injuries for males and females were the workplace and home, respectively. Open-globe injuries occurred in ~70% of eyes, requiring primary repair, cataract extraction, and/or intraocular lens implantation. The frequencies of fall injury, lacrimal system laceration, lens injury, corneal/scleral foreign bodies, and use of intracameral antibiotics increased from 2002–2004 to 2012–2014, while those of closed-globe injury, vitreous haemorrhage, optic nerve injury, and medical treatment decreased. The final visual acuity remained poor (≤20/200) in >1/3 of injured eyes. Despite therapeutic advancements, major eye injuries still pose a high risk for poor visual outcome.


  • Open Access

    Orbital complications of paranasal sinusitis in Taiwan, 1988 through 2015: Acute ophthalmological manifestations, diagnosis, and management

    by Yi-Sheng Chang, Po-Lin Chen, Jia-Horung Hung, Hsiao-Yen Chen, Chun-Chieh Lai, Chun-Yen Ou, Chia-Ming Chang, Chien-Kuo Wang, Hon-Chun Cheng, Sung-Huei Tseng

    Paranasal sinusitis is widespread and can lead to orbital complications, blindness, and death. However, the correlation between ophthalmological findings and disease staging remains unclear. This study aimed to investigate the staging, acute ophthalmological manifestations, diagnosis, management, and outcomes of orbital complications of paranasal sinusitis during a 27-year period. We retrospectively reviewed the medical records of all patients with orbital complications of paranasal sinusitis hospitalized at the National Cheng Kung University Hospital, a medical center in Taiwan during 1988–2015. Sex, age, symptoms, history, ophthalmological findings, laboratory and imaging findings, treatments, and outcomes were analyzed by staging. Eighty-three patients aged 9 days to 80 years had stage I (preseptal cellulitis, n = 39 patients), II (postseptal orbital cellulitis, n = 8), III (subperiosteal abscess, n = 16), IV (orbital abscess, n = 8), or V (intracranial involvement, n = 12) complications. Peak incidences occurred in patients aged 0–19 and 60–69 years. Chronic sinusitis and diabetes mellitus were common preexisting diseases. Extraocular movement limitation and proptosis predicted postseptal (stage II or more) involvement. The likelihood of elevated intraocular pressure increased with stage. Reduced visual acuity and presence of relative afferent pupillary defect indicated consideration of magnetic resonance imaging to investigate possible intracranial extension. Ipsilateral maxillary (81.7%) and ethmoidal (75.6%) sinuses were the most common sources of infection, and the most frequently implicated pathogens were coagulase-negative Staphylococcus spp. (25.3%) and Staphylococcus aureus (20.5%). All patients received intravenous antimicrobial therapy (multi-drug therapy in 88.0%), and 55.4% underwent surgery, most commonly endoscopic sinus surgery. One (1.2%) diabetic man with stage V complications died of fungal sinusitis with intracranial invasion. Five (6.0%) patients, all stage V, lost vision despite intensive treatment. The average length of hospital stay was 13.8 days (range 2–72 days), and significantly longer stays were associated with stages II–V as compared to stage I. Orbital infection originating from paranasal sinusitis can cause vision loss and death due to intracranial extension. Acute ophthalmological findings predict staging and prognosis. Cooperative consultation between ophthalmologists, otorhinolaryngologists, and neurologists is essential. Urgent diagnostic studies and aggressive antimicrobial therapy are indicated, and surgery should be considered.


  • Ocular ischemic syndrome

    by Jia-Horung Hung, Yi-Sheng Chang